Funding for this research was provided by:
LSH-TKI Foundation (LSHM15036)
Received: 9 August 2019
Accepted: 4 November 2019
First Online: 14 November 2019
Ethics approval and consent to participate
: The study (ExternalRef removed Identifier NCT03968679) will be conducted in accordance with the Declaration of Helsinki and the ICH Harmonized Tripartite Guideline for Good Clinical Practice. The study has been approved by the local research ethics committee (Medical Research Ethics Committee of the Netherlands Cancer Institute/Antoni van Leeuwenhoek, protocol ID: NL68958.031.19). All patients are given oral and written information about the study, and are given sufficient time to consider participating. Written informed consent must be obtained from each patient before inclusion.
: Not applicable.
: The authors declare that they have no competing interests.